Experience of time and subjective age when facing a limited lifetime

• Verfasst von: Laryionava, Katsiaryna [VerfasserIn]
• Verfasst von: Schönstein, Anton [VerfasserIn]
• Verfasst von: Heußner, Pia [VerfasserIn]
• Verfasst von: Hiddemann, Wolfgang [VerfasserIn]
• Verfasst von: Winkler, Eva C. [VerfasserIn]
• Verfasst von: Wahl, Hans-Werner [VerfasserIn]
• Titel: Experience of time and subjective age when facing a limited lifetime
• Titelzusatz: the case of older adults with advanced cancer
• Verf.angabe: Katsiaryna Laryionava, Anton Schönstein, Pia Heußner, Wolfgang Hiddemann, Eva C. Winkler, and Hans-Werner Wahl
• Jahr: 2022
• Umfang: 14 S.
• Fussnoten: First published online December 30, 2021 ; Gesehen am 06.02.2023
• Titel Quelle: Enthalten in: Journal of aging and health
• Ort Quelle: London [u.a.] : Sage Publ., 1989
• Jahr Quelle: 2022
• Band/Heft Quelle: 34(2022), 4-5, Seite 736-749
• ISSN Quelle: 1552-6887
• DOI: doi:10.1177/08982643211063162
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1833337964
• K10plus-PPN:
  Universitätsbibliothek
• Lokale URL UB: Zum Volltext

Abstract

ObjectivesWe addressed two questions: (1) Does advanced cancer in later life affect a person?s awareness of time and their subjective age? (2) Are awareness of time and subjective age associated with distress, perceived quality of life, and depression?MethodsWe assessed patients suffering terminal cancer (OAC, n = 91) and older adults free of any life-threatening disease (OA, n = 89), all subjects being aged 50 years or older.ResultsOlder adults with advanced cancer perceived time more strongly as being a finite resource and felt significantly older than OA controls. Feeling younger was meaningfully related with better quality of life and less distress. In the OA group, feeling younger was also associated to reduced depression. Perceiving time as a finite resource was related to higher quality of life in the OA group.DiscussionMajor indicators of an older person?s awareness of time and subjective aging differ between those being confronted with advanced cancer versus controls.